EU Greenlights Rezurock for Chronic GVHD: A Much-N...
Category : Product Related Updates 2 April 2026A new treatment option has entered the European market for one of the most challenging post-transpla...
A new treatment option has entered the European market for one of the most challenging post-transpla...
Pricing is strategy. And today, Novo Nordisk made a decisive move in India. Effective April 1, 2026,...
Long-term consistency is rare in eczema treatment. Eli Lilly and Company just shared new data showin...
Eisai Co., Ltd. will present new research on Lecanemab, its therapy for Alzheimer's disease, at...
Altamira Therapeutics announced that its associate company, Altamira Medica, has received a notice o...